Nicotine occupies a strange position in pharmacology: it is one of the most addictive substances humans regularly consume, yet it also has measurable cognitive, metabolic, and even neuroprotective benefits that researchers continue to study. The honest answer to “what are the pros and cons” is that nicotine’s effects depend heavily on who is using it, how they get it, and how long they use it. Separating the molecule from the cigarette changes the risk picture dramatically, but it does not eliminate risk.
How Nicotine Sharpens Attention
Nicotine’s most consistently demonstrated benefit is its effect on attention. Both animal studies and human trials show improvements in sustained attention, working memory, fine motor skills, and certain types of memory when nicotine is administered in controlled doses.1PubMed Central. Cognitive Effects of Nicotine: Recent Progress These effects are not subtle placebo responses. In one human study using a rapid visual information task, nicotine produced dose-dependent improvements in sustained attention, with hit accuracy climbing as the dose increased.2PubMed Central. Validation of the human odor span task: effects of nicotine In animal models, nicotine enhanced sustained attention on tasks that demanded focus over longer periods, particularly when baseline performance was relatively low to begin with.3PubMed. Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys
The cognitive picture is not uniformly positive, though. That same human study found no significant effect of nicotine on broader measures of working memory like digit span, spatial span, or letter-number sequencing.2PubMed Central. Validation of the human odor span task: effects of nicotine Nicotine seems to be good at boosting a narrow slice of cognition, particularly the ability to stay vigilant and detect signals in a stream of noise, rather than upgrading overall mental performance. If you are hoping for a general-purpose brain booster, the evidence is more modest than the headlines suggest.
The Parkinson’s Disease Puzzle
One of the most intriguing findings about nicotine is the consistent inverse relationship between tobacco use and Parkinson’s disease. Epidemiological studies have found that smokers develop Parkinson’s at lower rates than non-smokers, and researchers have attributed at least part of that effect to nicotine itself.4PubMed Central. Nicotine and Parkinson’s disease: implications for therapy Animal studies support the idea: in Parkinson’s models, nicotine administration slowed the degeneration of dopamine-producing neurons and reduced behavioral symptoms.5PubMed Central. Proposed mechanisms of neuroprotection for nicotine in Parkinson’s disease
Before anyone takes this as a reason to start using nicotine, the gap between animal models and clinical reality matters here. A systematic review of the experimental evidence concluded that while preclinical data look promising, these neuroprotective findings have not been adequately confirmed in randomized controlled trials involving humans.6IBRO Neuroscience Reports. The effects of nicotine on Parkinson’s disease: A systematic review and meta-analysis of experimental evidence The direction of the association is clear, but whether giving nicotine to people at risk for Parkinson’s would actually prevent the disease remains unproven. It is also possible that reverse causation plays a role: people in the early stages of Parkinson’s may find nicotine less rewarding and therefore be less likely to smoke.
Weight, Metabolism, and Appetite
Ask anyone who has quit smoking what happened to their weight, and the answer is usually “it went up.” Nicotine influences body weight through at least two pathways. It modifies appetite-regulating signals in the brain, and it ramps up energy expenditure. Reviews of the evidence show that nicotine increases resting energy expenditure and physical activity energy expenditure in both smokers and non-smokers, while simultaneously altering hypothalamic signals that govern hunger.7Appetite. Nicotine and energy balance: A review examining the effect of nicotine on hormonal appetite regulation and energy expenditure
In rats, self-administered nicotine shifted metabolism toward burning fat over carbohydrates, and this metabolic shift appeared even before any weight change showed up, suggesting the fat-burning effect is direct rather than a downstream consequence of eating less.8PubMed Central. Self-administered nicotine increases fat metabolism and suppresses weight gain in male rats The weight-suppression effect is real, but it is not a free lunch. The metabolic benefits disappear when nicotine use stops, and the addiction risk that comes along for the ride makes nicotine a terrible weight-management strategy for anyone who is not already dependent on it.
A Mild Painkiller
Nicotine also appears to raise pain thresholds. A meta-analysis looking at both pain threshold and pain tolerance found that nicotine delivered through any route, whether smoked, patched, or sprayed, produced acute analgesic effects of small to moderate size.9PubMed Central. Acute Analgesic Effects of Nicotine and Tobacco in Humans: A Meta-Analysis The effect is not strong enough to compete with purpose-built painkillers, but it may help explain why smokers sometimes report that cigarettes “take the edge off” physical discomfort. It also complicates smoking cessation, because quitting removes a low-level analgesic that the person may not even realize they have been relying on.
The Addiction Problem
The single biggest con of nicotine is how effectively it hijacks your brain’s reward circuitry. Nicotine drives continued use even when users know the consequences are harmful. It achieves this primarily by increasing the firing rate and burst activity of dopamine neurons in the midbrain, acting through specific receptor subtypes.10PubMed Central. Reward, addiction, withdrawal to nicotine With repeated exposure, the brain adapts to the constant presence of nicotine. These neuroadaptations create a state in which the brain needs nicotine to function at what feels like baseline, and removing it produces withdrawal: irritability, difficulty concentrating, anxiety, and sleep disruption.
Withdrawal is not just unpleasant; it feeds into broader mental health problems. Research has shown that nicotine withdrawal severity can mediate the relationship between everyday stressors and insomnia, particularly when depressive symptoms are already present.11ScienceDirect / Addictive Behaviors. Discrimination and insomnia: Examining depressive symptoms and nicotine withdrawal through a serial mediation model in a sample of smokers The irony is that many of the “benefits” regular smokers report, like stress relief and improved focus, may simply be the reversal of withdrawal rather than a genuine enhancement above normal function.
Cardiovascular Risk
Nicotine is a powerful activator of the sympathetic nervous system. When it binds to receptors in the adrenal glands and autonomic ganglia, it triggers a release of stress hormones that acutely raise heart rate, blood pressure, and the heart’s oxygen demand.12European Heart Journal. Nicotine and the cardiovascular system: unmasking a global public health threat For someone with healthy arteries, the occasional spike may be tolerable. For someone with existing cardiovascular disease, those repeated spikes add up.
The cardiovascular story gets more nuanced when you separate nicotine from combusted tobacco. Swedish snus, an oral tobacco product that delivers nicotine without smoke, was not associated with increased risk of peripheral artery disease in a prospective cohort study. Users had essentially the same risk as people who never used snus.13Scientific Reports. Swedish snuff (snus) dipping, cigarette smoking, and risk of peripheral artery disease: a prospective cohort study This suggests that much of smoking’s cardiovascular devastation comes from combustion byproducts rather than nicotine alone. But “less harmful than cigarettes” is a low bar, and researchers have emphasized that nicotine itself is not cardiovascularly inert, especially with chronic daily use.12European Heart Journal. Nicotine and the cardiovascular system: unmasking a global public health threat
Risks for Adolescents and Pregnant Women
Two populations face outsized risk from nicotine: teenagers and fetuses. In adolescents, nicotine exposure disrupts the normal maturation of the prefrontal cortex, the brain region responsible for planning, impulse control, and attention. Animal studies have shown that nicotine during adolescence, but not after the brain has matured, leads to lasting reductions in attention span and increased impulsivity.14PubMed Central. Nicotine and the adolescent brain Even brief, low-dose exposure equivalent to a couple of cigarettes per day for just four days made adolescent rats more likely to self-administer other drugs afterward, supporting the idea that early nicotine use can prime the brain for broader addiction vulnerability.14PubMed Central. Nicotine and the adolescent brain
During pregnancy, nicotine appears to be the key ingredient in tobacco smoke responsible for harming fetal lung development. Because nicotine itself, rather than the tar or carbon monoxide, drives this damage, e-cigarettes are considered similarly dangerous to fetal lungs as conventional cigarettes.15PubMed Central. Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health For pregnant women looking to quit smoking, nicotine replacement therapy involves a calculated trade-off between the fetus’s continued exposure to smoke versus exposure to nicotine alone, a decision best made with a physician.
Nicotine Replacement for Quitting Smoking
The most established medical use of nicotine is, paradoxically, helping people stop consuming it through combustion. Nicotine replacement therapy, including gum, patches, nasal spray, inhalers, and lozenges, increases the odds of successfully quitting smoking by roughly 50 to 60 percent compared to placebo. A large Cochrane review found high-quality evidence for this benefit across all licensed forms of NRT, regardless of the setting in which it was offered.16PubMed Central. Nicotine replacement therapy versus control for smoking cessation Earlier meta-analyses found more modest absolute efficacy rates, with 2 mg nicotine gum contributing about a 6 percentage-point improvement over placebo, but with greater effectiveness in people who sought out help on their own rather than those who were recruited.17PubMed Central. How effective is nicotine replacement therapy in helping people to stop smoking?
The success of NRT is, in some ways, the best illustration of the nicotine paradox. The substance is addictive enough that you need it to quit itself, but clean enough in isolation that regulated medical products delivering it are considered safe enough for widespread over-the-counter sale.
Nicotine and Ulcerative Colitis
One of the more surprising therapeutic applications involves inflammatory bowel disease. Clinicians noticed decades ago that ulcerative colitis patients who smoked often saw their symptoms improve, and that quitting could trigger flares. Transdermal nicotine patches have been studied as a treatment, and a Cochrane review of controlled trials found that nicotine patches led to clinical remission in a meaningfully higher proportion of patients compared to placebo.18PubMed. Transdermal nicotine for induction of remission in ulcerative colitis A broader review of the literature found that nicotine patches alone did not outperform placebo, but when combined with conventional therapy they provided a meaningful additional benefit. The catch was that side effects from the patches were frequent enough that compliance suffered.19PubMed Central. Transdermal Nicotine as a Treatment Option for Ulcerative Colitis: A Review Nicotine is not a first-line treatment for the condition, but it remains an active area of investigation for patients who do not respond well to standard drugs.
Nicotine and Schizophrenia
Smoking rates among people with schizophrenia are dramatically higher than in the general population, and the self-medication hypothesis offers one explanation: nicotine may compensate for specific cognitive and sensory-processing deficits that are central to the disorder.20PubMed. Nicotine use in schizophrenia: the self medication hypotheses In a rat model of schizophrenia, nicotine self-administration significantly improved cognitive deficits that had been induced prenatally, lending experimental support to the idea that people with the disorder may genuinely derive functional cognitive benefits from nicotine.21PubMed. Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia The tragedy is that the delivery system most available, cigarettes, imposes enormous health costs on a population already facing reduced life expectancy. Developing cleaner nicotine delivery options for psychiatric patients is an area where public health interests and neuroscience overlap in an uncomfortable way.
Delivery Method Changes the Risk Equation
How nicotine enters your body matters almost as much as whether it does. A cigarette delivers nicotine wrapped in thousands of toxic combustion products. A nicotine patch delivers the same molecule with negligible additional toxicants. The rapidly growing market of tobacco-free oral nicotine pouches sits somewhere in this landscape, and chemical analyses suggest they are closer to the clean end of the spectrum. Compared to Swedish snus, oral nicotine pouches contained lower levels of the vast majority of tested toxicants, often by more than 90 percent.22BMC Chemistry. Toxicant contents of oral nicotine pouches: comparative quantitative analysis with Swedish snus and cigarette smoke When compared with historical cigarette smoke data, the differences were even more dramatic. A separate analysis placed these pouches close to licensed nicotine replacement products on the toxicant delivery spectrum.23PubMed. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums
Yet lower toxicant levels do not mean lower nicotine doses. Some high-strength nicotine pouches deliver nearly double the peak nicotine blood level of a cigarette, with 30 mg pouches producing peak concentrations around 29 ng/mL compared to about 15 ng/mL from a cigarette.24PubMed Central. Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches From an addiction standpoint, that is not trivial. A product that is toxicologically cleaner but delivers more nicotine per use could easily create stronger dependence, even if it causes less tissue damage.
How Much Nicotine Is Dangerous
The commonly cited lethal dose of nicotine, roughly 60 mg for an adult, has been repeated in textbooks for over a century. It turns out to be wrong. A forensic review traced the number back to dubious self-experiments from the 1800s and found that well-documented cases of acute nicotine poisoning point to a lethal oral dose above 500 mg, or more than four times higher than the old estimate.25PubMed Central. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century This does not make nicotine safe in large quantities. Accidental ingestion, especially by children who find nicotine pouches or liquid refills, can cause severe vomiting, seizures, and cardiac arrhythmias well below the lethal threshold. But the corrected number matters for poison control guidance and risk communication: the margin between a therapeutic dose and a deadly one is wider than most people assume.
Nicotine and the Gut Microbiome
A newer line of research looks at what nicotine does to the trillions of bacteria living in the gut. In mice, four weeks of oral nicotine reduced body weight and fat on both normal and high-fat diets, but the gut microbiome effects diverged sharply depending on what the mice ate. On a high-fat diet, nicotine more aggressively disrupted bacterial diversity and community composition, and it worsened blood markers like lipids, glucose, and inflammatory molecules. On a normal diet, those metabolic parameters stayed relatively stable.26Biomedicine & Pharmacotherapy. Four-week administration of nicotine moderately impacts blood metabolic profile and gut microbiota in a diet-dependent manner Separately, inhaled nicotine was found to alter gut microbial communities in both male and female mice, but the effects were sex-dependent: nicotine reduced overall bacterial diversity only in females.27PubMed Central. Sex-Dependent Effects of Inhaled Nicotine on the Gut Microbiome This is still early-stage research, but it points to an underappreciated dimension of nicotine’s effects that may influence everything from inflammation to nutrient absorption.
Why Nicotine Exists in the First Place
Nicotine was never designed for human brains. The tobacco plant evolved the molecule as a defense against insects. Field studies have shown that plants unable to produce nicotine suffer markedly more damage from leafhoppers and aphids, and those lacking both nicotine and other chemical defenses are even more vulnerable to a broader range of insect pests.28PubMed Central. Acylsugars, Nicotine and a Protease Inhibitor Provide Variable Protection for Nicotiana benthamiana in a Natural Setting The molecule functions as a natural insecticide. That humans happened to have receptors it could bind to, and that binding produced a complex mix of pleasure, alertness, and dependence, is essentially an evolutionary accident. Nicotine’s pharmacological richness in humans is a side effect of its original purpose: being toxic enough to discourage a caterpillar from chewing through a leaf.